Fri. 5 Apr 2024, 7:20am ET
Benzinga
News, Health Care, Financing, Offerings, General
Subject to Biodesix stockholder approval, each share of Series A Non-Voting Convertible Preferred Stock will automatically convert to 40 shares of common stock for an aggregate of 30,434,280 shares of common stock.